Regulatory Intelligence & Guidance Monitoring

Regulatory intelligence turns FDA guidance, Federal Register notices, draft policies, and enforcement patterns into decisions your program can use. Without a structured watch, teams learn about new guidances too late, miss comment opportunities, or discover inspection themes only after a finding lands on a related product, competitor, or contract manufacturing site in your network.

Viltis builds monitoring routines sized to your portfolio. We track relevant CDER, CBER, and CDRH updates, summarize what changed, and assess impact on INDs, marketing applications, devices under 510(k)/De Novo/PMA, and marketed products. Intelligence is only useful when it reaches the people who own protocols, CMC files, labeling, and quality systems, with a named owner for follow-up actions and a due date that sticks.

We favor short, actionable briefings over long digests nobody reads. Impact notes call out which SOPs, study designs, or submission modules may need revision, and we help you prioritize follow-up with regulatory and quality owners. Precedent and advisory committee themes can also inform meeting strategy and risk discussions with leadership before you commit to a costly development path or manufacturing change.

Intelligence without triage becomes noise. We help you filter by product class, indication, and stage so a small RA team can stay current without reading every Federal Register notice published in a given week, while still catching the few updates that change your next filing. For device and combination product programs, we include CDRH guidance and recognized standards updates in the same watch so software, cybersecurity, and labeling changes are not treated as afterthoughts to drug-centric monitoring routines.

Regulatory intelligence activities typically include

• Scheduled monitoring of FDA guidance and policy releases
• Impact assessments for pipeline and marketed products
• Tracking of Warning Letters, 483 themes, and enforcement trends
• Briefings for RA, clinical, CMC, and quality stakeholders
• Support for public comment drafting on draft guidance
• Competitive and therapeutic-area precedent scans for meetings
• Living intelligence trackers tied to your product list

Good intelligence shortens reaction time when expectations shift. Viltis helps your team stay current without drowning in alerts that do not change what you do next week or next quarter. The measure of intelligence work is fewer surprises in meetings and inspections, not thicker inboxes.